Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 31;13(6):513.
doi: 10.3390/antibiotics13060513.

Multidisciplinary Perspectives of Challenges in Infective Endocarditis Complicated by Septic Embolic-Induced Acute Myocardial Infarction

Elena Stamate  1   2 , Oana Roxana Ciobotaru  2   3 , Manuela Arbune  2   4 , Alin Ionut Piraianu  2   5 , Oana Monica Duca  2   5 , Ana Fulga  2   6 , Iuliu Fulga  2   6 , Alexia Anastasia Stefania Balta  2   6 , Adrian George Dumitrascu  7 , Octavian Catalin Ciobotaru  2   3
Affiliations
Review

Multidisciplinary Perspectives of Challenges in Infective Endocarditis Complicated by Septic Embolic-Induced Acute Myocardial Infarction

Elena Stamate et al. Antibiotics (Basel). .

Abstract

Background: Infective endocarditis (IE) management is challenging, usually requiring multidisciplinary collaboration from cardiologists, infectious disease specialists, interventional cardiologists, and cardiovascular surgeons, as more than half of the cases will require surgical procedures. Therefore, it is essential for all healthcare providers involved in managing IE to understand the disease's characteristics, potential complications, and treatment options. While systemic embolization is one of the most frequent complications of IE, the coronary localization of emboli causing acute myocardial infarction (AMI) is less common, with an incidence ranging from 1% to 10% of cases, but it has a much higher rate of morbidity and mortality. There are no guidelines for this type of AMI management in IE.

Methods: This narrative review summarizes the current knowledge regarding septic coronary embolization in patients with IE. Additionally, this paper highlights the diagnosis and management challenges in such cases, particularly due to the lack of protocols or consensus in the field.

Results: Data extracted from case reports indicate that septic coronary embolization often occurs within the first two weeks of the disease. The aortic valve is most commonly involved with vegetation, and the occluded vessel is frequently the left anterior descending artery. Broad-spectrum antibiotic therapy followed by targeted antibiotic therapy for infection control is essential, and surgical treatment offers promising results through surgical embolectomy, concomitant with valve replacement or aspiration thrombectomy, with or without subsequent stent insertion. Thrombolytics are to be avoided due to the increased risk of bleeding.

Conclusions: All these aspects should constitute future lines of research, allowing the integration of all current knowledge from multidisciplinary team studies on larger patient cohorts and, subsequently, creating a consensus for assessing the risk and guiding the management of this potentially fatal complication.

Keywords: antibiotic therapy; coronary; endocarditis; myocardial infarction; septic embolism.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Challenges in infective endocarditis complicated by septic embolic-induced acute myocardial infarction.
Figure 2
Figure 2
Future directions in combating the burden of endocarditis.
Figure 3
Figure 3
Valves involved in infective endocarditis complicated by septic embolic-induced acute myocardial infarction.
Figure 4
Figure 4
Infective endocarditis complicated by different types of septic embolic-induced acute myocardial infarction.
Figure 5
Figure 5
Culture results in patients with infective endocarditis complicated by septic embolic-induced acute myocardial infarction.
Figure 6
Figure 6
The role of the multidisciplinary team in managing endocarditis.
See this image and copyright information in PMC

References

    1. Momtazmanesh S., Saeedi Moghaddam S., Malakan Rad E., Azadnajafabad S., Ebrahimi N., Mohammadi E., Rouhifard M., Rezaei N., Masinaei M., Rezaei N., et al. Global, Regional, and National Burden and Quality of Care Index of Endocarditis: The Global Burden of Disease Study 1990–2019. Eur. J. Prev. Cardiol. 2022;29:1287–1297. doi: 10.1093/eurjpc/zwab211. - DOI - PubMed
    1. Rizzo V., Salmasi M.Y., Sabetai M., Primus C., Sandoe J., Lewis M., Woldman S., Athanasiou T. Infective Endocarditis: Do We Have an Effective Risk Score Model? A Systematic Review. Front. Cardiovasc. Med. 2023;10:1093363. doi: 10.3389/fcvm.2023.1093363. - DOI - PMC - PubMed
    1. Kildahl H.A., Brenne E.L., Dalen H., Wahba A. Systemic Embolization in Infective Endocarditis. Indian J. Thorac. Cardiovasc. Surg. :2023. doi: 10.1007/s12055-023-01616-2. - DOI - PMC - PubMed
    1. Amri M., Tamir E.M., Drighil A., Habbal R. An Infective Endocarditis Complicated by Multiple Septic Emboli: Case Report. Egypt. Heart J. 2024;76:19. doi: 10.1186/s43044-024-00451-z. - DOI - PMC - PubMed
    1. Cabezón G., López J., Vilacosta I., Sáez C., García-Granja P.E., Olmos C., Jerónimo A., Gutiérrez Á., Pulido P., de Miguel M., et al. Reassessment of Vegetation Size as a Sole Indication for Surgery in Left-Sided Infective Endocarditis. J. Am. Soc. Echocardiogr. 2022;35:570–575. doi: 10.1016/j.echo.2021.12.013. - DOI - PubMed

LinkOut - more resources